ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ophiopogonin D attenuates the progression of murine systemic lupus erythematosus by reducing B cell numbers

Nie, Yingkun*; Li, Chunyan; Sun, Ni哈尔滨医科大学
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY2023-7DOI: 10.1002/jbt.23361
8阅读
引用收藏
分享

摘要

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by immune abnormalities leading to multi-organ damage. The activation of autoreactive B cell differentiation will lead to the production of pathogenic autoantibodies, contributing to the development of SLE. However, the effects of Ophiopogonin D (OP-D) on B cell activation and autoantibody production as well as renal injury in the pathogenesis of SLE remain unclear. MRL/lpr mice, one of the most commonly used animal models of SLE, were intragastrically administered with 5 mg/kg/d OP-D at 17 weeks of age for 3 weeks. The survival rates of mice in each group were monitored for 6 weeks until 23 weeks of age. Proteinuria and serum creatinine levels were measured. Serum levels of immunoglobulin (Ig)G, IgM, and anti-dsDNA autoantibodies were detected by enzyme-linked immunosorbent assay. Numbers of CD19(+) B cells in the blood, spleen and bone marrow and numbers of splenic germinal center (GC) B cells were calculated by using flow cytometry. OP-D treatment prolonged survival in MRL/lpr mice. OP-D treatment reduced proteinuria and serum creatinine levels as well as mitigated renal pathological alternation in MRL/lpr mice. Furthermore, serum levels of IgG, IgM, and anti-dsDNA autoantibodies were reduced by OP-D treatment. OP-D lessened not only CD19(+) B cells in the spleen and bone marrow but also plasma cells that secreted anti-dsDNA autoantibodies, IgG and IgM in the spleen and bone marrow. OP-D ameliorated the progression of SLE by inhibiting the secretion of autoantibodies though reducing B cell numbers.

学科与关键词

关键词
autoantibodiesB cellOphiopogonin Drenal injurySystemic lupus erythematosus
相关
加载中…
  • IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis
    Ma, Kongyang; Du, Wenhan; Xiao, Fan; Han, Man; Huang, Enyu; Peng, Na; Tang, Yuan; Deng, Chong; Liu, Lixiong; Chen, Yulan; Li, Jingjing; Yuan, Shiwen; Huang, Qin; Hong, Xiaoping; Hu, Dajun; Cai, Xiaoyan; Jiang, Quan; Liu, Dongzhou; Lu, Liwei*Cellular & Molecular Immunology, 2021, 18(7): 1739-1750.被引 20
  • The suppression of Brd4 inhibits peripheral plasma cell differentiation and exhibits therapeutic potential for systemic lupus erythematosus
    Zeng, Shan; Qiu, Qian; Zhou, Yi; Xiao, Youjun; Li, Ruiru; Xu, Siqi; Shi, Maohua; Kuang, Yu; Lao, Minxi; Cai, Xiaoyan*; Liang, Liuqin*; Xu, Hanshi*; Wang, Jingnan; Wang, CuicuiInternational Immunopharmacology, 2022, 103: 108498.
  • Cell-based therapies for systemic lupus erythematosus
    Liao Jieyue; Chang Christopher; Wu Haijing; Lu Qianjin*Autoimmunity Reviews, 2015, 14(1): 43-48.
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
发表日期
2023-07
卷期
第 37 卷, 第 7 期
DOI
10.1002/jbt.23361
语言
ENGLISH
成果收录
SCIE

作者

  • N

    Nie, Yingkun (通讯) (第一作者)

    2 · harbin med univ

  • L

    Li, Chunyan

    2 · harbin med univ

查看全部 3 位作者收起作者
  • S

    Sun, Ni

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417